Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. is dated June 23, 2023. The report serves to notify shareholders of the upcoming Annual General Meeting of Shareholders scheduled for July 31, 2023, at 3:00 p.m. Israel time at the company's offices in Petach Tikva, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this filing. The document focuses solely on corporate governance procedures for the upcoming annual meeting.
Guidance, Outlook, and Management Commentary
There is no financial guidance, outlook, or management commentary regarding business operations in this filing. The document provides details on voting procedures, including the availability of a Notice and Proxy Statement, a Proxy Card for ordinary share holders, and a Voting Instruction Card for American Depositary Share holders.
Key Facts for Investor Verification
- Annual General Meeting date: July 31, 2023.
- Meeting location: 10 Bareket Street, Petach Tikva, Israel.
- Shareholders may vote in person or by proxy using the attached forms.
- This filing incorporates by reference into the company's Registration Statements on Form S-8 and Form F-3.
- No financial performance data is included in this specific report.